Phentermine And Topiramate (Qsymia)

Description

INDICATIONS & USAGE SECTION:

• Qsymia is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of
• Limitations of Use
• Qsymia is a combination of phentermine, a sympathomimetic amine anorectic, and topiramate extended-release, an antiepileptic drug, indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of:

DOSAGE & STRENGHTS

• Qsymia capsules are formulated in the following four strength combinations (phentermine mg/topiramate mg extended-release):
• Capsules: (phentermine mg/topiramate mg extended-release)

• 3.75 mg/23 mg (n n n )n n n
• 7.5 mg/46 mg (n n n )n n n
• 11.25 mg/69 mg (n n n )n n n
• 15 mg/92 mg (n n n )n n n